12alpha,14beta- dihydroxy- 2alpha,3beta- (tetrahydro- 3',5'- dihydroxy- 4'- methoxy- 6'- methyl- 2H- pyran- 2',4'- diylbisoxy)- card- 4,20- dienolid

structure in first source

Also Known As:

fugaxin

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Ischemic Stroke 10/18/2018 - "The symptomatic patients were defined as those who experienced nondisabling ischemic stroke or transient cerebralis chemic symptoms, including hemispheric events oramaurosis fugaxin the last 6 months. "